Skip to content

Medtronic MDT Other Operating Segments, Including Diabetes — Total Assets

Similar metrics at other companies

BRI
BRIDAll Other Segments — Total Assets
$24.23M+18.0%
Village Farms International, Inc. logo
VFFAll Other Segments — Total Assets
$49.2M
Artesian Resources logo
ARTNAAll Other Segments — Total Assets
$7.97M+8.7%
Gyre Therapeutics, Inc. logo
GYREAll Other Segments — Total Assets
$357K-2.2%
Warrior Met Coal logo
HCCAll Other Segments — Total Assets
$153.13M+14.3%
BancFirst Corporation logo
BANFAll Other Segments — Total Assets
$119.39M+16.6%

Other financials

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$106.51B-9.6%
Enterprise value$133.77B-7.9%
P/E22.2×-3.1×
P/S2.9×-0.6×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp
FCF margin14.9%-0.5pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Medtronic’s 10-K, filed June 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medtronic's other operating segments, including diabetes — total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medtronic's other operating segments, including diabetes — total assets?
Medtronic (MDT) reported other operating segments, including diabetes — total assets of $4.83B in Q1 2026.
What does other operating segments, including diabetes — total assets mean?
This metric represents the total value of assets allocated to or utilized by the secondary operating segments, including the diabetes business. It encompasses property, plant, equipment, and other resources dedicated to the production and distribution of these specific medical devices. It serves as a basis for evaluating the capital intensity and return on assets for these business units.